東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Development and characterization of ...

Hill, Reginald.

FindBook

Google Book

Amazon

博客來

Development and characterization of a mouse model of human prostate cancer.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Development and characterization of a mouse model of human prostate cancer./
作者:	Hill, Reginald.
面頁冊數:	148 p.
附註:	Source: Dissertation Abstracts International, Volume: 66-03, Section: B, page: 1276.
Contained By:	Dissertation Abstracts International66-03B.
標題:	Biology, Genetics. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3170457
ISBN:	9780542066771

Development and characterization of a mouse model of human prostate cancer.
Hill, Reginald.

Development and characterization of a mouse model of human prostate cancer. - 148 p.

Source: Dissertation Abstracts International, Volume: 66-03, Section: B, page: 1276.

Thesis (Ph.D.)--The University of North Carolina at Chapel Hill, 2005.

While previous studies using genetically engineered mice (GEM) have indicated potential effects of several aberrations observed in human prostate cancer, the most common early event, loss of pRb function, has not been fully assessed. Using GEMS, we show that complete inactivation of the pRb family proteins (Rb/p107/p130) is sufficient to produce prostatic intraepithelial neoplasia (PIN) lesions that consist of highly proliferative and apoptosic epithelial cells. In order to gain a full understanding of the selective pressures produced by complete pRb family inactivation and their impact on tumor progression, we studied the resulting pressures that led to altered Pten function, the most frequent change in advanced prostate tumors. Consequently it was found that Pten hemizygosity reduced apoptosis by 50%, accelerating tumor onset, and the selective progression to complete Pten loss of function yields distinct tumor properties, thereby uncovering at least one mechanism by which the observed heterogeneity of human prostate cancers can develop. In addition to Pten, we studied the effect alteration of p53 had on prostate tumorigenesis. No changes in epithelium proliferation or apoptosis were seen with p53 deficiency, hinting that if p53 does have a tumor suppressive function in the prostate, it is not in the epithelial compartment.

ISBN: 9780542066771Subjects--Topical Terms:

1017730
Biology, Genetics.

Development and characterization of a mouse model of human prostate cancer.
LDR:03205nmm 2200289 4500 001 1824316
005 20061130141905.5
008 130610s2005 eng d
020 $a 9780542066771
035 $a (UnM)AAI3170457
035 $a AAI3170457
040 $a UnM $c UnM
100 1 $a Hill, Reginald. $3 1386961
245 1 0 $a Development and characterization of a mouse model of human prostate cancer.
300 $a 148 p.
500 $a Source: Dissertation Abstracts International, Volume: 66-03, Section: B, page: 1276.
500 $a Adviser: Terry A. Van Dyke.
502 $a Thesis (Ph.D.)--The University of North Carolina at Chapel Hill, 2005.
520 $a While previous studies using genetically engineered mice (GEM) have indicated potential effects of several aberrations observed in human prostate cancer, the most common early event, loss of pRb function, has not been fully assessed. Using GEMS, we show that complete inactivation of the pRb family proteins (Rb/p107/p130) is sufficient to produce prostatic intraepithelial neoplasia (PIN) lesions that consist of highly proliferative and apoptosic epithelial cells. In order to gain a full understanding of the selective pressures produced by complete pRb family inactivation and their impact on tumor progression, we studied the resulting pressures that led to altered Pten function, the most frequent change in advanced prostate tumors. Consequently it was found that Pten hemizygosity reduced apoptosis by 50%, accelerating tumor onset, and the selective progression to complete Pten loss of function yields distinct tumor properties, thereby uncovering at least one mechanism by which the observed heterogeneity of human prostate cancers can develop. In addition to Pten, we studied the effect alteration of p53 had on prostate tumorigenesis. No changes in epithelium proliferation or apoptosis were seen with p53 deficiency, hinting that if p53 does have a tumor suppressive function in the prostate, it is not in the epithelial compartment.
520 $a So far, analyses of genetic lesions in human cancers have focused on the accumulation of multiple events within the epithelial cancer cell. Yet, several studies have demonstrated clear micro-environment influences on developing tumors implicating non-tumor cell responses as a critical component of tumorigenesis. Moreover, analyses of some carcinomas have indicated the presence of tumor suppressor gene mutations within the stroma. Such observations suggest the possibility that multiple cell types selectively co-evolve through micro-environment changes during tumor progression. In our prostate cancer model, we show that selective inactivation of p53 within the mesenchyme occurs in response to epithelial tumorigenesis and indeed contributes to progression of the cancer. All of these studies have generated a preclinical animal model which both genetically and biologically models the course of human prostate cancer.
590 $a School code: 0153.
650 4 $a Biology, Genetics. $3 1017730
650 4 $a Health Sciences, Oncology. $3 1018566
690 $a 0369
690 $a 0992
710 2 0 $a The University of North Carolina at Chapel Hill. $3 1017449
773 0 $t Dissertation Abstracts International $g 66-03B.
790 1 0 $a Van Dyke, Terry A., $e advisor
790 $a 0153
791 $a Ph.D.
792 $a 2005
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3170457